Skip to main content
Premium Trial:

Request an Annual Quote

Merrimack Gets NCI Phase I SBIR Grant for Protein Microarrays

NEW YORK, Jan. 29 (GenomeWeb News) - Merrimack Pharmaceuticals has received a Phase I SBIR Grant from the National Cancer Institute, the company said today.


Merrimack said it will use the grant, "Protein Microarrays in Cancer Drug Discovery," to develop and apply its microarray technology to apoptosis and cancer.


"The protein microarray research in this grant, combined with Merrimack's expertise in computational modeling and high-throughtput biology, should yield tremendous results in this difficult field," Michael Cardone, the company's director of science development, said in a statement.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.